Alemtuzumab by continuous intravenous infusion followed by subcutaneous injection plus rituximab in the treatment of patients with chronic lymphocytic leukemia recurrence (Q35766117)
Jump to navigation
Jump to search
scientific article published on May 2010
Language | Label | Description | Also known as |
---|---|---|---|
English | Alemtuzumab by continuous intravenous infusion followed by subcutaneous injection plus rituximab in the treatment of patients with chronic lymphocytic leukemia recurrence |
scientific article published on May 2010 |
Statements
1 reference
Alemtuzumab by continuous intravenous infusion followed by subcutaneous injection plus rituximab in the treatment of patients with chronic lymphocytic leukemia recurrence (English)
1 reference
Alessandra Ferrajoli
1 reference
Stefan Faderl
1 reference
William Wierda
1 reference
Susan O'Brien
1 reference
Michael J Keating
1 reference
Susan Lerner
1 reference
1 May 2010
1 reference
1 reference
116
1 reference
10
1 reference
2360-2365
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference